Keystone eSymposia Logo

Global Priorities in Vaginal Health: Microbes, Mucosal Immunity and Interventions

November 10-12, 2021
*Program is in development and subject to change



 Attention


The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 3 months following the event.


 Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries


Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest. Application must be completed by February 1, 2022.


Apply Here


The female genital tract environment represents an intricate interplay between commensal microbes, pathogens, small molecule metabolites and host immune cells resulting in health and disease consequences for women, their sexual partners, and neonates. Refined characterization of the genital tract using sophisticated methods has expanded our understanding of mucosal immunology, the microbiome, the metabolome, and the proteome. Mechanisms leading to adverse outcomes, particularly elevated risk of HIV acquisition, are being unraveled, and an increasing number of interventions are in clinical trials. In this meeting, we will examine cutting-edge knowledge needed to tackle some of the most challenging global problems in reproductive and sexual health, including current understanding of female genital tract microbiology and immunology, and advances in therapeutics and preventatives intended to modify or protect these environments. Potential mechanisms leading to adverse outcomes, and prospective prevention and/or treatment interventions will be presented and discussed. Pathways for development of novel interventions, including industry partnership and regulatory strategies will be considered. The progress made in recent years at the bench and in clinical trials should inform global health interventions aimed at sustaining sexual and reproductive health for women especially in resource-limited settings, where women suffer the most severe consequences of these challenges.

Apply Here for Free On Demand Access

Pricing:

Regular Registration Rate: $275 USD
Student Registration Rate: $150 USD

Deadlines:

Abstract Submission
‣ For Short Talk Consideration: Passed
‣ For ePoster Presentation: Passed
Final ePoster / SciTalk Submission: Passed
Financial Aid Application: Passed

*Abstract submission is required in order to submit an ePoster and/or Scitalk

#VKSVaginalHealth22




Program Details



Program details will be available soon.

Keynote Speaker


[Pedro L. Alonso, MD, PhD]

[Pedro L. Alonso, MD, PhD]
[World Health Organization, Director of the Global Malaria Programme]




Speaking at this eSymposia


Kingsley C. Anukam

Nnamdi Azikiwe University, Nigeria


Eric Armstrong

University of Toronto, Canada


Emily P. Balskus

Harvard University, USA


Yasmine Belkaid

NIAID, National Institutes of Health, USA


Robert D. Burk

Albert Einstein College of Medicine, USA


Craig R. Cohen

University of California, San Francisco, USA


Bhabatosh Dos

Translational Health Science and Technology Institute, India


David N. Fredricks

Fred Hutchinson Cancer Research Center, USA


Betsy Herold

Albert Einstein College of Medicine, USA


Susan P. Holmes

Stanford University, USA


Heather B. Jaspan

Seattle Children's Research Institute / University of Cape Town, USA


Douglas S. Kwon

Harvard Medical School, USA


Jordan K. Kyongo

East Africa Research & Innovation Hub, Kenya


Lenine Liebenberg

CAPRISA, South Africa


Jeanne M. Marrazzo

University of Alabama at Birmingham, USA


Lindi Masson

Burnet Institute, Australia


Lyle McKinnon

University of Manitoba, Canada


Caroline M. Mitchell

Massachusetts General Hospital, USA


Sinaye Ngcapu

CAPRISA, South Africa


Jo-Ann S. Passmore

University of Cape Town, South Africa


Sujatha Srinivasan

Fred Hutchinson Cancer Research Center, USA


Jill Steinbach-Rankins

University of Louisville, USA


Janneke van de Wijgert

University Medical Center Utrecht, Netherlands







Sponsors


 

sponsor-carousel-cellpress.png

 




Additional Support



sponsor-carousel-bmgf.png

sponsor-carousel-nci.png

sponsor-carousel-novus.png

Funding for this conference was made possible (in part) by Grant No. [GRANT NUMBER - UPDATE] from the National Institutes of Health. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.




Media-in-Kind Support


sponsor-carousel-cellpress.png

sponsor-carousel-jcb-jem.png

sponsor-carousel-embo.png

sponsor-carousel-frontiers.png

Sponsor-Carousel-Leibert-Publishing.png

Sponsor-Carousel-nature-portfolio.png

 

sponsor-carousel-scientist.png

 





The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.






#ScienceMustGoOn



This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community.  Here, Debbie Johnson, our CEO, explains how we're going to do that.




Donate to Keystone Symposia


Donate to Keystone Symposia